NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo

Cited by (657)

Items 401–500 of 657

1. Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue
   Stefan Saretz, Gabriele Basset, Liridona Useini, Markus Laube, Jens Pietzsch, Dijana Drača, Danijela Maksimović‐Ivanić, Johannes Trambauer, Harald Steiner, Evamarie Hey‐Hawkins · 2021 · Molecules
2. Common Factors of Alzheimer’s Disease and Rheumatoid Arthritis—Pathomechanism and Treatment
   Paulina Trzeciak, Mariola Herbet, Jarosław Dudka · 2021 · Molecules
3. S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicity
   Andis Klegeris, John A. Maguire, Patrick L. McGeer · 2004 · Journal of Neuroimmunology
4. Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside
   Nathan O. Fuller, Jed L. Hubbs, Wesley Austin, Steffen P. Creaser, Timothy D. McKee, Robyn M. B. Loureiro, Barbara A. Tate, Weiming Xia, Jeffrey L. Ives, Mark A. Findeis et al. · 2012 · ACS Medicinal Chemistry Letters
5. Complex Relationships between Substrate Sequence and Sensitivity to Alterations in γ-Secretase Processivity Induced by γ-Secretase Modulators
   Joo In Jung, Yong Ran, Pedro E. Cruz, Awilda M. Rosario, Thomas B. Ladd, Thomas L. Kukar, Edward H. Koo, Kevin M. Felsenstein, Todd Eliot Golde · 2014 · Biochemistry
6. NSAID-Based γ-Secretase Modulators Do Not Bind to the Amyloid-β Polypeptide
   Paul J. Barrett, Charles R. Sanders, Stephen A. Kaufman, Klaus Michelsen, John B. Jordan · 2011 · Biochemistry
7. A Subset of Membrane-Altering Agents and γ-Secretase Modulators Provoke Nonsubstrate Cleavage by Rhomboid Proteases
   Siniša Urban, Syed Mohammad Moin · 2014 · Cell Reports
8. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease
   Myuri T. Ruthirakuhan, Nathan Herrmann, Ivonne Suridjan, Eleenor H Abraham, Ilan Farber, Krista L. Lanctôt · 2016 · Expert Opinion on Pharmacotherapy
9. Challenges in Designing Therapeutic Agents for Treating Alzheimer’s Disease-from Serendipity to Rationality
   Umer Rashid, Farzana Latif Ansari · 2014 · Elsevier eBooks
10. Combining an amyloid‐beta (Aβ) cleaving enzyme inhibitor with a γ‐secretase modulator results in an additive reduction of Aβ production
    Kia Strömberg, Susanna Eketjäll, Biljana Georgievska, Karin Tunblad, Kristina Eliason, Fredrik Olsson, Ann‐Cathrin Radesäter, Rebecka Klintenberg, Per I. Arvidsson, Stefan von Berg et al. · 2014 · FEBS Journal
11. NO‐flurbiprofen reduces amyloid‐β, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade
    Samer O. Abdul‐Hay, Jia Luo, Rezene T. Asghodom, Gregory R. J. Thatcher · 2009 · Journal of Neurochemistry
12. Enantioselective resolution of racemic flurbiprofen methyl ester by lipase encapsulated mercapto calix[4]arenes capped Fe3O4 nanoparticles
    Hasan Yildiz, Elif Özyılmaz, Asif Ali Bhatti, Mustafa Yılmaz · 2017 · Bioprocess and Biosystems Engineering
13. Exposure to CuO Nanoparticles Mediates NFκB Activation and Enhances Amyloid Precursor Protein Expression
    Xiaoyang Mou, Alexander R. Pilozzi, Breeya A Tailor, Jing Yi, Catherine M. Cahill, Jack T. Rogers, Xudong Huang · 2020 · Biomedicines
14. Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator
    Joo In Jung, Ashleigh R. Price, Thomas B. Ladd, Yong Ran, Hyo-Jin Park, Carolina Ceballos‐Diaz, Lisa A. Smithson, Günther Hochhaus, Yufei Tang, Rajender Akula et al. · 2015 · Molecular Neurodegeneration
15. Looking for novel ways to treat the hallmarks of Alzheimer's disease
    Alistair J. Stewart, Anthony W. Fox, Bruce H. Morimoto, Illana Gozes · 2007 · Expert Opinion on Investigational Drugs
16. Effects of nonsteroidal anti-inflammatory drugs on amyloid-β pathology in mouse skeletal muscle
    Tina L. Beckett, Dana M. Niedowicz, Christa M. Studzinski, Adam M. Weidner, Robin L. Webb, Christopher J. Holler, Rachel R. Ahmed, Harry LeVine, Michael Paul Murphy · 2010 · Neurobiology of Disease
17. New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels
    Piera Sozio, Lisa Marinelli, Ivana Cacciatore, Antonella Fontana, Hasan Türkez, Gianfabio Giorgioni, Dario Ambrosini, Francesco Barbato, Lucia Grumetto, Stéphanie Pacella et al. · 2013 · Molecules
18. The geminal dimethyl analogue of Flurbiprofen as a novel Aβ42 inhibitor and potential Alzheimer’s disease modifying agent
    Nicholas S. Stock, Benito Muñoz, Jonathan D.J. Wrigley, Mark S. Shearman, Dirk Beher, James Peachey, Toni L. Williamson, Gretchen Bain, Weichao Chen, Xiaohui Jiang et al. · 2006 · Bioorganic & Medicinal Chemistry Letters
19. Effects of non-steroidal anti-inflammatory drugs on Aβ deposition in Aβ1–42 transgenic C. elegans
    Masahiko Morita, Kazuhiko Osoda, Mayako Yamazaki, Fumiyuki Shirai, Nobuya Matsuoka, Hiroyuki Arakawa, Shintaro Nishimura · 2009 · Brain Research
20. A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study
    Shafq Al-azzawi, Dhafir Masheta, Anna L. Guildford, Gary J. Phillips, Matteo Santin · 2020 · Nanomaterials
21. Indomethacin Disrupts the Formation of β-Amyloid Plaques via an α2-Macroglobulin-Activating lrp1-Dependent Mechanism
    Pei-Pei Guan, Liuqing Yang, Guo‐Biao Xu, Pu Wang · 2021 · International Journal of Molecular Sciences
22. Supervised Learning Based Hypothesis Generation from Biomedical Literature
    Shengtian Sang, Zhihao Yang, Zongyao Li, Hongfei Lin · 2015 · BioMed Research International
23. Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach
    Zhili Xin, Hairuo Peng, Andrew J. Zhang, Tina Talreja, Gnanasambandam Kumaravel, Lin Sen Xu, Ellen Rohde, Mi-yong Jung, Melanie N. Shackett, David A. Kocisko et al. · 2011 · Bioorganic & Medicinal Chemistry Letters
24. Reciprocal relationship between APP positioning relative to the membrane and PS1 conformation
    Kengo Uemura, Katherine C Farner, Navine Nasser‐Ghodsi, P. Jones, Oksana Berezovska · 2011 · Molecular Neurodegeneration
25. Flurbiprofen
    Alaa A.‐M. Abdel‐Aziz, Abdullah A. Al‐Badr, Gamal Abdel Hafez · 2012 · Profiles of drug substances, excipients, and related methodology
26. Chronic ibuprofen treatment does not affect the secondary pathology in the thalamus or improve behavioral outcome in middle cerebral artery occlusion rats
    Anu Lipsanen, Mikko O. Hiltunen, Jukka Jolkkonen · 2011 · Pharmacology Biochemistry and Behavior
27. Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery
    Mahmoud M. Sheha · 2012 · Archives of Pharmacal Research
28. Alzheimer therapeutics—what after the cholinesterase inhibitors?
    Lary C. Walker, Rebecca F. Rosen · 2006 · Age and Ageing
29. Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles
    Thaís Del Rosario Hernández, Sayali V. Gore, Jill A. Kreiling, Robbert Créton · 2024 · Biomedicine & Pharmacotherapy
30. Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds
    Nora Astrain-Redín, Irene Talavera, Esther Moreno, María Javier Ramírez, Nuria Martínez‐Sáez, Ignacio Encı́o, Arun Kumar Sharma, Carmen Sanmartín, Daniel Plano · 2023 · Antioxidants
31. Nose to brain delivery of flurbiprofen from a solid lipid nanoparticles-based thermosensitive in-situ gel.
    Ashok J Choudhary, Sakshi Mahajan, Anuradha Sandeep Majumdar · 2024 · Neuroscience Applied
32. Conversion of the LXR-agonist TO-901317—From inverse to normal modulation of γ-secretase by addition of a carboxylic acid and a lipophilic anchor
    Rajeshwar Narlawar, Karlheinz Baumann, Christian Czech, Boris Schmidt · 2007 · Bioorganic & Medicinal Chemistry Letters
33. TASTPM Mice Expressing Amyloid Precursor Protein and Presenilin-1 Mutant Transgenes Are Sensitive to γ-Secretase Modulation and Amyloid-β42 Lowering by GSM-10h
    Ishrut Hussain, David C. Harrison, Julie Hawkins, Trevor D. Chapman, Ian Marshall, Laura Facci, Sharlin F. Ahmed, Kim T. Brackenborough, Stephen D. Skaper, Tania L. Mead et al. · 2010 · Neurodegenerative Diseases
34. Interaction between Drug Loaded Polyaspartamide-Polylactide-Polysorbate Based Micelles and Cell Membrane Models: A Calorimetric Study
    Maria Grazia Sarpietro, Giovanna Laura Pitarresi, Sara Ottimo, Maria Chiara Giuffrida, Maria Chiara Ognibene, Calogero Fiorica, Gaetano Giammona, Francesco Castelli · 2011 · Molecular Pharmaceutics
35. Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach
    Alejo J. Nevado‐Holgado, Simon Lovestone · 2016 · Computational and Structural Biotechnology Journal
36. Anti-Alzheimer and Anti-Cox-2 Activities of the Newly Synthesized 2,3′-Bipyridine Derivatives (I)
    Fawzy Ali Attaby, Azza M. Abdel‐Fattah, Labeeb M. Shaif, Mohamed M. Elsayed · 2009 · Phosphorus, sulfur, and silicon and the related elements
37. Selective modulation of amyloid‐β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels
    Samer O. Abdul‐Hay, Praneeth D. Edirisinghe, Gregory R. J. Thatcher · 2009 · Journal of Neurochemistry
38. Structural and Chemical Biology of Presenilin Complexes
    Douglas S. Johnson, Yue‐Ming Li, Martin Pettersson, Peter St George‐Hyslop · 2017 · Cold Spring Harbor Perspectives in Medicine
39. Tarenflurbil
    Mary Sano · 2010 · Archives of Neurology
40. Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer
    Fokhrul M. Hossain, Deniz A. Uçar, Giulia Monticone, Yong Ran, Samarpan Majumder, Kristina Larter, Hanh Luu, Dorota Danuta Wyczechowska, Soroor Heidari, Keli Xu et al. · 2023 · Frontiers in Immunology
41. The Recent Updates of Therapeutic Approaches Against Aβ for the Treatment of Alzheimer's Disease
    Shucai Ling, Jing Zhou, John Anthony Rudd, Zhiying Hu, Marong Fang · 2011 · The Anatomical Record
42. Current Experimental Therapy for Alzheimers Disease
    Sheng Chen, Xiao-Jie Zhang, Liang Li, Wei-Dong Le · 2007 · Current Neuropharmacology
43. Ibuprofen partially attenuates neurodegenerative symptoms in presenilin conditional double-knockout mice
    Zhao Hui Dong, Yan Li, Guan J. Huang, L. Zhang, Bing Mei, Bo Meng · 2014 · Neuroscience
44. Oxidative stress in a rat model of chronic gliosis
    Kristyn Alissa Bates, Ralph Nigel Martins, Alan R. Harvey · 2006 · Neurobiology of Aging
45. Inclusion-body myositis and Alzheimer disease
    Michael Paul Murphy, Todd Eliot Golde · 2006 · Neurology
46. The Amyloid β Protein
    Noel D. Lazo, Samir Kumar Maji, Erica A. Fradinger, Gal Bitan, David B. Teplow · 2005 · Wiley eBooks
47. Ibuprofen Inhibits the Synaptic Failure Induced by the Amyloid-β Peptide in Hippocampal Neurons
    Maria Paz Zurita, Gonzalo Muñoz, Fernando J. Sepúlveda, Paulina Gómez, Carolina Castillo, Carlos Felipe Burgos, Jorge Fuentealba, Carlos Opazo, Luis Gerardo Aguayo · 2013 · Journal of Alzheimer s Disease
48. Identification of an Ene Reductase from Yeast Kluyveromyces Marxianus and Application in the Asymmetric Synthesis of (R)‐Profen Esters
    Zhining Li, Zexu Wang, Ge Meng, Hong Lu, Zedu Huang, Fen‐Er Chen · 2018 · Asian Journal of Organic Chemistry
49. Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.
    Massimo F L Pomponi, Giovanni Gambassi, Massimiliano Pomponi, Carlo Masullo · 2010 · Europe PMC (PubMed Central)
50. Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
    I‐Fang Ling, Todd Eliot Golde, Douglas R Galasko, Edward H. Koo · 2015 · Alzheimer s Research & Therapy
51. Nonsteroidal anti-inflammatory drugs attenuate amyloid-β protein-induced actin cytoskeletal reorganization through Rho signaling modulation
    Patricia Ferrera, Angélica Zepeda, Clorinda Arias · 2017 · Cellular and Molecular Neurobiology
52. Chapter 3 Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease
    Richard E. Olson, Lawrence R. Marcin · 2007 · Annual reports in medicinal chemistry
53. Failure, Success, and Future Direction of Alzheimer Drugs Targeting Amyloid‐β Cascade: Pros and Cons of Chemical and Biological Modalities
    Jimin Kim, Hanna Jeon, Hye Yun Kim, Young Soo Kim · 2023 · ChemBioChem
54. A new methodology for simultaneous quantification of total-Aβ, Aβx-38, Aβx-40, and Aβx-42 by column-switching LC/MS/MS
    Kenichi Watanabe, Chihiro Ishikawa, Hiroshi Kuwahara, Kimihiko Sato, Setsuko Komuro, Tetsuya Nakagawa, Naruaki Nomura, Shiro Watanabe, Masashi Yabuki · 2011 · Analytical and Bioanalytical Chemistry
55. Synthesis of L-Ascorbyl Flurbiprofenate by Lipase-Catalyzed Esterification and Transesterification Reactions
    Jiaying Xin, Lirui Sun, Shuming Chen, Yan Wang, Chungu Xia · 2017 · BioMed Research International
56. Recent Studies on Design and Development of Drugs Against Alzheimer’s Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents
    Satya P. Gupta, Vaishali Manikrao Patil · 2020 · Current Topics in Medicinal Chemistry
57. Disease‐modifying treatments for Alzheimer's disease: A perspective based on experience with R‐Flurbiprofen
    Gordon Keith Wilcock · 2006 · Alzheimer s & Dementia
58. Mild Cognitive Impairment
    2006 · Wiley eBooks
59. Sporadic inclusion body myositis: an unsolved mystery.
    Pedro Machado, Adrian Miller, Janice L. Holton, Michael G. Hanna · 2009 · PubMed
60. Efficient four‐drug cocktail therapy targeting amyloid‐β peptide for Alzheimer's disease
    Masashi Asai, Nobuhisa Iwata, Taisuke Tomita, Takeshi Iwatsubo, Shoichi Ishiura, Takaomi C. Saido, Kei Maruyama · 2010 · Journal of Neuroscience Research
61. Chirality as a problem of biochemical physics
    V. A. Tverdislov, L. V. Yakovenko, Alex A. Zhavoronkov · 2007 · Russian Journal of General Chemistry
62. An Approach to Polysubstituted Triazipines, Thiadiazoles and Thiazoles Based on Benzopyran Moiety Through The Utility of Versatile Hydrazonoyl Halides as In Vitro Monoamine Oxidase Inhibitors
    Mohamed Gomaa Badrey, Sobhi M. Gomha, Wael A. A. Arafa, Mohamed M. Abdulla · 2016 · Journal of Heterocyclic Chemistry
63. Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy chinese male volunteers
    Yanmei Liu, Gangyi Liu, Yun Liu, Shuijun Li, Jingying Jia, Mengqi Zhang, Chuan Lü, Yongmei Zhang, Xuening Li, Chen Yu · 2009 · Clinical Therapeutics
64. Identification and Preclinical Pharmacology of the γ -Secretase Modulator BMS-869780
    Jeremy H. Toyn, Lorin A. Thompson, Kimberley A. Lentz, Jere E. Meredith, Catherine R. Burton, Sethu Sankaranararyanan, Valerie L. Guss, Tracey Hall, Lawrence G. Iben, Carol Krause et al. · 2014 · International Journal of Alzheimer s Disease
65. Solubility of Flurbiprofen in CO2 and CO2 + Methanol
    Gui Jin. Chin, Zi Hui Chee, Wenda Chen, Arvind Rajendran · 2009 · Journal of Chemical & Engineering Data
66. Flurbiprofen: A Potent Pain Reliever
    Maroof K Zafar F · 2015 · Journal of Bioequivalence & Bioavailability
67. Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: A RPE specific phenomenon
    Sudha Ananth, Lina Zhuang, Elangovan Gopal, Shiro Itagaki, Ellappan Babu, Sylvia B. Smith, Vadivel Ganapathy, Pamela Moore Martin · 2010 · Biochemical and Biophysical Research Communications
68. Tarenflurbil: a shot on goal
    Paul S. S Aisen · 2008 · The Lancet Neurology
69. The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeutics
    Kevin Mullane, Michael J. Williams · 2019 · Current Opinion in Pharmacology
70. Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
    Miren Ettcheto, Elena Sánchez‐López, Amanda C. Cano, Marina Carrasco, Katherine Herrera, Patrícia Regina Manzine, Triana Espinosa-Jiménez, Oriol Busquets, Ester Verdaguer, Jordi Olloquequi et al. · 2021 · Cell & Bioscience
71. γ-Secretase inhibitors: still in the running as Alzheimer’s therapeutics
    Els Marjaux, Bart De Strooper · 2004 · Drug Discovery Today Therapeutic Strategies
72. NSAID-derived γ-secretase modulators. Part III: Membrane anchoring
    Stefanie Baumann, Nicole Höttecke, Robert Schubenel, Karlheinz Baumann, Boris Schmidt · 2009 · Bioorganic & Medicinal Chemistry Letters
73. Drug Treatments in Development for Alzheimer's Disease
    Michael C. Woodward · 2012 · Journal of Pharmacy Practice and Research
74. SAR studies of acidic dual γ-secretase/PPARγ modulators
    Martina Hieke, Julia Neß, Ramona Steri, Christine Greiner, Oliver Werz, Manfred Schubert‐Zsilavecz, Sascha Weggen, Heiko Zettl · 2011 · Bioorganic & Medicinal Chemistry
75. Flurbiprofen-loaded Nanoparticles Can Cross a Primary Porcine In vitro Blood-brain Barrier Model to Reduce Amyloid-β42 Burden
    Julia Stäb, Iavor Zlatev · 2016 · Journal of Nanomedicine & Biotherapeutic Discovery
76. No apparent effect of naproxen on CSF markers of innate immune activation
    Pierre‐François Meyer, Anne Labonté, Pedro Rosa‐Neto, Judes Poirier, John C.S. Breitner · 2019 · Annals of Clinical and Translational Neurology
77. NSAIDs in the treatment and/or prevention of neurological disorders
    Parto S. Khansari, Leanne Coyne · 2012 · Inflammopharmacology
78. Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs
    Lizhi Liu, Summon Huq, Weiming Xu · 2009 · Current Signal Transduction Therapy
79. Aducanumab delivery via focused ultrasound-induced transient blood–brain barrier opening in vivo
    Jeong, Jaeyeong, Han, Mun, Jeon, Soyeon, Kim, Yejin, Choi, Hyo Jin, Choi, Woohyuk, Kwon, Kihyun, Choi, Jong-ryul, Lee, Eun-Hee · 2025 · Scientific Reports
80. Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivo
    Yunhong Huang, Ting Li, Andrew J. Eatherton, William L. Mitchell, Na Rong, Liang Ye, Xiujuan Yang, Shiyi Jin, Yu Ding, Jinqiang Zhang et al. · 2013 · Neuropharmacology
81. Amyloid-modifying therapies for Alzheimer’s disease: therapeutic progress and its implications
    Meaghan C. Creed, Norton William Milgram · 2010 · AGE
82. Brain‐Specific Delivery of Naproxen Using Different Carrier Systems
    Mahmoud M. Sheha, Mohammad Alhawi · 2010 · Archiv der Pharmazie
83. γ-Secretase Modulators and Inhibitors Induce Different Conformational Changes of Presenilin 1 Revealed by FLIM and FRET
    Xin Wang, Jin Cui, Wei Li, Xianglu Zeng, Jian Zhao, Gang Pei · 2015 · Journal of Alzheimer s Disease
84. γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease
    Douglas S. Johnson, Martin Pettersson · 2017 · Topics in medicinal chemistry
85. Alternative Approaches to the Search for Alzheimer’s Disease Treatments
    Eric J. C. Lien, James David Adams Jr., Linda Lin-min Lien, Meng Law · 2018 · J — Multidisciplinary Scientific Journal
86. Novel flurbiprofen derivatives with improved brain delivery: synthesis, in vitro and in vivo evaluations
    Dan Zheng, Xiao Shuai, Yanping Li, Peng Zhou, Tao Gong, Xun Sun, Zhirong Zhang · 2014 · Drug Delivery
87. Synthesis of Ibuprofen Conjugated Molecular Transporter Capable of Enhanced Brain Penetration
    Goutam K. Biswas, Wanil Kim, Kyong‐Tai Kim, Junhwi Cho, Dongjun Jeong, Keon‐Hyoung Song, Jungkyun Im · 2017 · Journal of Chemistry
88. [The teaching of pharmacology in medical schools: current status and future perspectives].
    Rodolfo Rodríguez Carranza, Horacio Vidrio, Efraín Campos-Sepúlveda · 2008 · PubMed
89. Neuronal zinc stores are modulated by non-steroidal anti-inflammatory drugs: An optical analysis in cultured hippocampal neurons
    Rachal Love, Gloria Salazar, Victor Faúndez · 2005 · Brain Research
90. Retinoid X receptor‐α mediates (R )‐flurbiprofen’s effect on the levels of Alzheimer’s β‐amyloid
    Xiaoqing You, Yun‐wu Zhang, Yaomin Chen, Xiumei Huang, Raymond Xu, Xihua Cao, Jiebo Chen, Yun Liu, Xiao-kun Zhang, Huaxi Xu · 2009 · Journal of Neurochemistry
91. γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing
    Tobias A. Weber, Johan Lundkvist, Johanna Wanngren, Hlin Kvartsberg, Shaobo Jin, Pia Larssen, Dan Wu, Daniel V. Oliveira, Karolina Minta, Gunnar Brinkmalm et al. · 2021 · Journal of Cellular and Molecular Medicine
92. A critical review on the role of nanotheranostics mediated approaches for targeting β amyloid in Alzheimer’s
    Vaibhav Rastogi, Anjali Jain, Prashant Kumar, Pragya Yadav, Mayur Porwal, Shashank Chaturvedi, Phool Chandra, Anurag Kumar Verma · 2023 · Journal of drug targeting
93. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates
    Yasuyuki Mitani, Hiroki Akashiba, Kyoko Saita, Junko Yarimizu, Hiroshi Uchino, Mayuko Okabe, Makoto Asai, Shingo Yamasaki, Takashi Nozawa, Noritoshi Ishikawa et al. · 2013 · Neuropharmacology
94. The Potential Effect of Fluorinated Compounds in the Treatment of Alzheimer’s Disease
    Bárbara Gomes, Joana A. Loureiro, Manuel A. N. Coelho, Maria do Carmo Pereira · 2015 · Current Pharmaceutical Design
95. An Over Expression APP Model for Anti-Alzheimer Disease Drug Screening Created by Zinc Finger Nuclease Technology
    Xiaojing Zhang, Hui Li, Yiqing Mao, Zhixin Li, Rong Wang, Tingting Guo, Ling Jin, Rongjing Song, Wei Xu, Na Zhou et al. · 2013 · PLoS ONE
96. NSAIDs in the prevention of dementia
    Jeremiah M. Scharf, Kirk R. Daffner · 2007 · Neurology
97. New Functions of Old Drugs: Aureolic Acid Group of Anti-Cancer Antibiotics and Non-Steroidal Anti-Inflammatory Drugs
    Hirak Chakraborty, Pukhrambam Grihanjali Devi, Munna Sarkar, Dipak Dasgupta · 2014 · Elsevier eBooks
98. Preparation of enantiopure (R)-flurbiprofen catalyzed by a newly isolatedBacillus cereusC71
    Li-Li Qian, Shaoxin Chen, Shi Bing-zhao · 2006 · Biocatalysis and Biotransformation
99. Enzyme Inhibitors Involved in the Treatment of Alzheimer’s Disease
    Vageesh Revadigar, Raza Murad Ghalib, Vikneswaran Murugaiyah, Mohamed A. Embaby, Ali H. Jawad, Sayed Hasan Mehdi, Rokiah Hashim, Othman Sulaiman · 2014 · Elsevier eBooks
100. Therapeutic Approaches for the Treatment of Alzheimer's Disease: An Overview
     Lit‐Fui Lau, Michael A. Brodney · 2007 · Springer eBooks